Yarrow Bioscience Inc YARW
18.78 USD +0.73 (+4.04%)
Nov 12, 2026, 1:27 PM EST
17.34 Day range 19.27
12.39 52-week range 46.95
- YTD
- -35.24%
- 1 year
- +6.70%
News
benzinga.com Yarrow Bioscience Q3 EPS $(0.43) Misses $(0.32) Estimate Yarrow Bioscience (NASDAQ:YARW) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.32) by 34.37 percent.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Lisata Therapeutics (NASDAQ:LSTA) stock rose 37.2% to $1.4 during Wednesday's regular session. The market value of their outstanding shares is at $11.0 million. BioStem Technologies…
benzinga.com This Palatin Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday Analysts initiated coverage: Neutral on KEEL ($2), Buy on PTN ($12), FRVO ($17) and YARW ($60).
benzinga.com Guggenheim Initiates Coverage On Yarrow Bioscience with Buy Rating, Announces Price Target of $60 Guggenheim analyst Yatin Suneja initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating and announces Price Target of $60.
247wallst.com Buy, Sell, or Hold? Friday’s Top Upgrades and Downgrades: Becton Dickinson, BJ’s Wholesale Club, Cogent Communications, Fervo Energy, JinkoSolar, Molson-Coors, Pfizer, SiTime, Steven Madden, and More After a brutal sell-off erased Wednesday's rally and dragged the Nasdaq back into correction territory, Wall Street analysts are still moving. Some reversed course on Pfizer, Molson Coors, and BJ's,…
benzinga.com Yarrow Bioscience Launches Underwritten Public Offering To Fund Pipeline Development And Corporate Operations; No Terms Disclosed Yarrow Bioscience, Inc. ("Yarrow" or the "Company") (NASDAQ:YARW), a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases, today…
benzinga.com Yarrow Bioscience Q2 EPS $(2.14) Misses $(0.22) Estimate Yarrow Bioscience (NASDAQ:YARW) reported quarterly losses of $(2.14) per share which missed the analyst consensus estimate of $(0.22) by 872.73 percent.
benzinga.com This Charles Schwab Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday Wall Street analysts changed outlook on top names. For full changes, see our analyst ratings page. Analysts have mixed opinions on SCHW stock.- benzinga.com BTIG Initiates Coverage On Yarrow Bioscience with Buy Rating, Announces Price Target of $58 BTIG analyst Julian Harrison initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating and announces Price Target of $58.